Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.4 |
mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.19 | 0.4 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.055 | 0.4 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |